Bafna Pharmaceuticals logo

Bafna Pharmaceuticals financials and balance sheet

NSE: BAFNAPHBSE: 532989Pharmaceuticals & BiotechnologySmall Cap

Last close ₹442.95down ₹9.00 (1.99%)BSE ₹449.85

Share price at the NSE close on 23 Oct 2026. Previous close ₹451.95.

52-week range of traded prices to 23 Oct 2026
₹94.77Low, 16 Mar 2026₹479.95High, 21 Oct 2026
Market cap
₹1,048 Cr2,105th largest listed
P/E
134.6
P/B
10.9
Dividend yield
Nonein the last 12 months
ROE
8.6%
ROCE
4.0%
Debt to equity
0.39
Volume, NSE
1,422

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Bafna Pharmaceuticals annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
A loss in 4 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

The years either side of a change of basis do not compare. From the year to Mar 2018, the company's revenue for that year, ₹47 Cr, differs from its quarters added, ₹77 Cr.

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue151
  2. Materials and goods−82
  3. Employee costs−22
  4. Other expenses−31
  5. Operating profit16
  6. Depreciation−6.1
  7. Other income+4.8
  8. One-off items0.0
  9. Finance costs−3.7
  10. Profit before tax11
  11. Tax+0.1
  12. Net profit11

What the company owns

  • Plant, investments and other assets₹101 Cr
  • Receivables₹44 Cr
  • Inventory₹29 Cr
  • Cash and bank₹2 Cr

What pays for it: net worth and liabilities

  • Net worth₹96 Cr
  • Borrowings₹37 Cr
  • Owed to suppliers₹31 Cr
  • Other liabilities₹11 Cr

Profit and loss

Standalone, ₹ crore, years to March.Bafna Pharmaceuticals quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 30 MayMar 2020Filed 25 JunMar 2021Filed 26 JunMar 2022Filed 7 JunMar 2023Filed 27 MayMar 2024Filed 9 JulMar 2025Filed 12 JunMar 2026Filed 29 May
Revenue from operations654743427185115152146151
708257416174100141135135
Materials and goods bought57443527455163878182
Employee costs7–910121516192122
Other expenses6–1343821363331
Operating profit before depreciation−5−35−131101116111116
Operating margin−8.0%−74.4%−30.8%2.9%14.5%13.5%13.6%7.3%7.7%10.6%
Materials, % of revenue88.4%–79.7%63.6%63.8%60.2%54.7%56.9%55.5%54.4%
Employee costs, % of revenue10.2%–20.8%24.1%16.8%17.0%13.8%12.5%14.4%14.6%
Other expenses, % of revenue9.5%–30.2%9.3%4.9%9.2%17.9%23.3%22.4%20.4%
Depreciation and amortisation4433455556
Operating profit after depreciation−9−39−17−266106610
Other income13110123435
Finance costs11720112234
Profit before one-off items and tax−19−14−18−267127611
One-off items––0−230−200−20
Profit before tax−19−14−18−2565127411
−1220000000
Net profit−18−16−20−2565117411
Other comprehensive income––00000000
Total comprehensive income––−20−2565117411
Net margin−28.4%−34.9%−45.5%−59.3%8.2%6.1%9.8%4.8%2.8%7.4%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2018 they do not, so they are left blank.
Earlier years, Mar 2008 to Mar 2016
₹ croreMar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Revenue from operations40467410112116717814385
3841679010614615611783
Materials and goods bought35386284941261309471
Employee costs122361114106
Other expenses21236913135
Operating profit before depreciation25811152121253
Operating margin4.8%11.2%10.5%11.0%12.8%12.5%11.9%17.8%3.3%
Materials, % of revenue88.7%82.4%83.5%82.8%77.7%75.5%73.2%66.0%83.5%
Employee costs, % of revenue1.4%3.3%3.2%3.1%4.7%6.3%7.8%7.3%7.5%
Other expenses, % of revenue5.1%3.2%2.8%3.1%4.8%5.6%7.1%9.0%5.6%
Depreciation and amortisation012268854
Operating profit after depreciation246910131320−1
Other income011143111
Finance costs1224811121212
Profit before one-off items and tax–3555529−13
One-off items0–−1−10––−3–
Profit before tax13455526−13
Tax011–31100
Net profit11232416−12
Net margin3.0%2.4%3.3%3.3%1.7%2.3%0.8%4.3%−14.3%
Standalone, ₹ crore, years to March.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Filed 30 MayMar 2020Filed 25 JunMar 2021Filed 26 JunMar 2022Filed 7 JunMar 2023Filed 27 MayMar 2024Filed 9 JulMar 2025Filed 12 JunMar 2026Filed 29 May
2151576373818596
Share capital242242424242424
Reserves−349333950576172
4603823242837
7120241646545257
29051110131622
121718690130148153176
7235373942536786
4836505187948590
Net debt44−81815232535
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Filed 26 JunMar 2022Filed 7 JunMar 2023Filed 27 MayMar 2024Filed 9 JulMar 2025Filed 12 JunMar 2026Filed 29 May
−8.66.55.09.522.115.4
−11.09.45.19.721.815.0
−21.4−1.3−14.6−5.38.3−5.3
Receivables−3.5−5.2−27.0−4.85.5−3.6
Inventories−4.0−4.8−1.9−7.41.2−0.8
Payables0.01.716.17.0−4.50.3
Other working capital−13.87.1−1.60.06.1−1.2
Tax paid0.00.0−0.1−0.20.40.3
Interest paid−0.1−0.80.00.00.00.0
Capital spending6.17.56.715.621.924.9
Free cash flow−14.7−1.0−1.8−6.10.3−9.5
6.1−4.5−7.5−15.1−21.2−22.4
12.4−3.610.2−0.81.15.6
Dividends paid0.00.00.00.00.00.0
Shares bought back0.00.00.00.00.00.0
Shares issued0.00.00.00.00.00.0
Net change in cash9.9−1.67.6−6.42.0−1.4
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.Bafna Pharmaceuticals dividend history

₹ per shareMar 2017Mar 2018Mar 2019Filed 30 MayMar 2020Filed 25 JunMar 2021Filed 26 JunMar 2022Filed 7 JunMar 2023Filed 27 MayMar 2024Filed 9 JulMar 2025Filed 12 JunMar 2026Filed 29 May
Earnings per share−₹9.90−₹8.82−₹8.34−₹106.54₹2.46–₹4.86₹3.11₹1.76₹4.69
Diluted earnings per share−₹9.90−₹8.82−₹8.34−₹106.54₹2.46–₹4.86₹3.11₹1.76₹4.69
Book value per share––₹8.79₹215.36₹24.00₹26.58₹31.05₹34.17₹35.85₹40.64
Shareholder yield––––0.0%0.0%0.0%0.0%0.0%0.0%
Market cap at the year end (₹ crore)55522331325300194185177259
Earnings per share is left blank for the year to Mar 2022: the earnings per share stated does not match any profit the filing states over the shares in issue, and the share count barely moved during the period.
RatioMar 2017Mar 2018Mar 2019Filed 30 MayMar 2020Filed 25 JunMar 2021Filed 26 JunMar 2022Filed 7 JunMar 2023Filed 27 MayMar 2024Filed 9 JulMar 2025Filed 12 JunMar 2026Filed 29 May
Revenue growth−23.9%–−8.1%−2.0%67.7%19.5%35.5%32.2%−4.3%3.3%
Operating profit growth––––738.1%11.6%36.7%−29.3%0.6%42.7%
Net profit growth–––––−11.6%120.1%−35.2%−43.5%167.3%
Earnings per share growth–––––––−36.0%−43.4%166.5%
––−94.9%−70.3%10.8%8.6%16.6%9.5%5.0%12.3%
–––24.6 pts81.1 pts−2.2 pts8.0 pts−7.1 pts−4.5 pts7.3 pts
From the net margin–––−28.9 pts80.0 pts−2.8 pts5.4 pts−8.5 pts−3.9 pts8.0 pts
From asset turnover–––−28.8 pts10.1 pts0.5 pts1.2 pts0.4 pts−0.7 pts−0.7 pts
From borrowing–––82.3 pts−8.9 pts0.1 pts1.4 pts1.0 pts0.1 pts0.0 pts
Return on capital employed––−25.0%−4.0%9.8%8.5%10.8%5.8%5.6%7.4%
Cash conversion––––−148.2%126.8%43.7%129.1%533.1%138.5%
Interest cover––––7.87.65.12.72.32.7
Debt to equity––2.220.000.040.130.310.300.330.39
Receivable days––209524963130109101106
Inventory days––98154124144129125127129
Payable days––4161698688165149140139
Cash conversion cycle, days––−109378711994848896
Working capital days––−1663121149150126109121
Asset turnover––0.360.440.900.961.051.100.970.92
Assets per rupee of net worth––5.802.671.461.481.611.801.821.82
Sales per rupee of plant––1.171.211.982.192.873.792.481.84
Capital spending to depreciation––––1.361.371.263.124.474.10
Plant being built, % of plant in use–––0.6%2.3%0.0%3.7%26.1%12.4%3.8%
Interest cover is left blank for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020: operating profit after depreciation is a loss, and a loss covers no interest bill. Revenue growth is left blank for the year to Mar 2018: between the two periods the company restated its earlier figures, so the two are on different bases and the change is not worked out. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
6.8%
Cash from operations against operating profit
96.4%
Measure10 years5 years3 years
Revenue growth, yearly rate5.8%16.2%9.3%
Profit growth, yearly rate–13.8%−0.7%
Return on equity, average–10.4%8.9%
Return on capital employed, average–7.6%6.3%
Operating margin, average−4.3%10.5%8.5%
Net margin, average−12.9%6.2%5.0%
Asset turnover, average–1.001.00
Cash conversion cycle, days, average–9689
Interest cover, average–4.12.6
Debt to equity, average–0.290.34

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations58.547.015.4
Cash from investing−70.7−58.6−22.4
Cash from financing12.45.85.6
Capital spending76.662.324.9
Dividends paid0.00.00.0
Shares bought back0.00.00.0
Shares issued for cash0.00.00.0
Borrowings raised31.814.59.2
Borrowings repaid9.80.00.0

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9467456
Altman Z-scorePublished threshold 1.818.538.804.233.783.473.89
Beneish M-scorePublished threshold −1.78−0.24−2.56–−0.55−3.22−2.76
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets10.583.5812.639.322.1111.03
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––0.130.881.602.08
Receivables growth less revenue growthOur threshold 0 percentage points−9.2735.06142.93−21.86−7.176.08
Inventory growth less cost-of-goods growthOur threshold 0 percentage points−32.8718.49−13.41−4.121.441.62
Other current assets growth less revenue growthOur threshold 5 per cent of revenue18.12−7.86−0.071.23−3.391.13
Assets under construction, years of additionsOur threshold 2 years of additions0.150.000.222.110.310.11
Effective tax ratePublished threshold 17.16 per cent0.000.002.400.000.00−1.18
Tax charged less tax paid, % of profitOur threshold 10 percentage points0.000.001.30−2.36−8.44−4.11
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
23 Jan 2026ICRA Limited (opens in a new tab)Interchangeable limits-Letter of credit[ICRA]A4+Review, Re-affirm5
23 Jan 2026ICRA Limited (opens in a new tab)Fund-based-Term loan[ICRA]BB+Review, Re-affirmPositive25.87
23 Jan 2026ICRA Limited (opens in a new tab)Fund-based-Cash credit[ICRA]BB+Review, Re-affirmPositive20
23 Jan 2026ICRA Limited (opens in a new tab)Unallocated limits-Unallocated limits[ICRA]BB+Review, Re-affirmPositive4.13
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.